Ken Okumura

Atrial fibrillation and chronic kidney disease

P38 MAP kinaseの抑制はマウスの圧負荷による病的心肥大を軽減し心機能低下を抑制する

Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed double-spaced) in length and may be subject to editing or abridgment.

response patients with coronary spastic angina: possible role for enhanced vasoconstrictor Enhanced phospholipase C activity in the cultured skin fibroblast obtained from

Left Ventricular Dysfunction and Advanced Heart Failure Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With

Effect and limitation of rhythm control strategy for paroxysmal atrial fibrillation: Pharmacologic and non-pharmacologic approaches

A SIMPLE CRITERION OF "V-H-A PATTERN BY VENTRICULAR EXTRASTIMULUS" FOR THE DIAGNOSIS OF ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA

RAPID ATRIAL PACING UPREGULATES SYNTHESIS OF ASYMMETRIC DIMETHYLARGININE IN CANINE AF MODEL

CLINICAL RELEVANCE OF PILSICAINIDE CHALLENGE TEST FOR RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN PATIENTS WITH BRUGADA TYPE ECG

AMIODARONE NOT ONLY REVERSES ELECTRICAL REMODELING BUT SUPPRESSES MATRIX METALLOPROTEINASES 2 ACTIVITY IN CANINE PACING-INDUCED PERSISTENT ATRIAL FIBRILLATION MODEL